白云山：分公司枸橼酸西地那非片获得《药品补充申请批准通知书》

证券日报11-06

证券日报网讯 11月6日晚间，白云山发布公告称，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，药品通用名称为枸橼酸西地那非片。（文章来源：证券日报）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2481606896?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-06 20:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481606896","market":"us","top_or_hot":-1,"title":"白云山：分公司枸橼酸西地那非片获得《药品补充申请批准通知书》","media":"证券日报","content":"<div>\n<p>证券日报网讯 11月6日晚间，白云山发布公告称，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，药品通用名称为枸橼酸西地那非片。（文章来源：证券日报）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202411063231396322.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>白云山：分公司枸橼酸西地那非片获得《药品补充申请批准通知书》</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n白云山：分公司枸橼酸西地那非片获得《药品补充申请批准通知书》\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-06 20:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202411063231396322.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券日报网讯 11月6日晚间，白云山发布公告称，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，药品通用名称为枸橼酸西地那非片。（文章来源：证券日报）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202411063231396322.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白云山","start_time":0,"source_url":"http://finance.eastmoney.com/a/202411063231396322.html","article_id":"2481606896","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481606896","pubTimestamp":1730896893,"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"证券日报网讯11月6日晚间，白云山发布公告称，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，药品通用名称为枸橼酸西地那非片。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00874":"白云山","BK1521":"挪威政府全球养老基金持仓","BK1191":"制药","BK1606":"中医药概念","BK1515":"抗疫概念","BK1197":"保健护理产品经销商"},"translate_title":"Baiyunshan: Sildenafil Citrate Tablets of the branch obtained the \"Notice of Approval of Supplementary Drug Application\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00874":1},"content_text":"证券日报网讯 11月6日晚间，白云山发布公告称，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，药品通用名称为枸橼酸西地那非片。（文章来源：证券日报）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481606896"}